1. Home
  2. NVCR vs MGRC Comparison

NVCR vs MGRC Comparison

Compare NVCR & MGRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • MGRC
  • Stock Information
  • Founded
  • NVCR 2000
  • MGRC 1979
  • Country
  • NVCR Jersey
  • MGRC United States
  • Employees
  • NVCR N/A
  • MGRC N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • MGRC Diversified Commercial Services
  • Sector
  • NVCR Health Care
  • MGRC Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • MGRC Nasdaq
  • Market Cap
  • NVCR 3.0B
  • MGRC 3.0B
  • IPO Year
  • NVCR 2015
  • MGRC N/A
  • Fundamental
  • Price
  • NVCR $30.97
  • MGRC $112.56
  • Analyst Decision
  • NVCR Buy
  • MGRC Buy
  • Analyst Count
  • NVCR 5
  • MGRC 2
  • Target Price
  • NVCR $33.40
  • MGRC $145.50
  • AVG Volume (30 Days)
  • NVCR 1.9M
  • MGRC 136.2K
  • Earning Date
  • NVCR 10-30-2024
  • MGRC 02-19-2025
  • Dividend Yield
  • NVCR N/A
  • MGRC 1.70%
  • EPS Growth
  • NVCR N/A
  • MGRC 23.19
  • EPS
  • NVCR N/A
  • MGRC 9.15
  • Revenue
  • NVCR $577,738,000.00
  • MGRC $888,783,000.00
  • Revenue This Year
  • NVCR $19.13
  • MGRC $12.08
  • Revenue Next Year
  • NVCR $5.38
  • MGRC $0.48
  • P/E Ratio
  • NVCR N/A
  • MGRC $12.31
  • Revenue Growth
  • NVCR 14.63
  • MGRC 12.06
  • 52 Week Low
  • NVCR $11.70
  • MGRC $95.50
  • 52 Week High
  • NVCR $34.13
  • MGRC $130.86
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 60.66
  • MGRC 28.57
  • Support Level
  • NVCR $29.85
  • MGRC $110.05
  • Resistance Level
  • NVCR $34.13
  • MGRC $119.79
  • Average True Range (ATR)
  • NVCR 2.00
  • MGRC 2.79
  • MACD
  • NVCR -0.33
  • MGRC -1.34
  • Stochastic Oscillator
  • NVCR 44.92
  • MGRC 4.59

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About MGRC McGrath RentCorp

McGrath RentCorp is a rental company. It is comprised of four reportable business segments: Modular building and portable storage segment (Mobile Modular), Electronic test equipment segment (TRS-RenTelco), Containment solutions for the storage of hazardous and non-hazardous liquids and solids segment (Adler Tanks) and Classroom manufacturing division selling modular classrooms in California (Enviroplex). The company generates its revenues majorily from the rental of its equipment on operating leases with sales of equipment occurring in the normal course of business.

Share on Social Networks: